The trademark DEMOS Pharmaceuticals was filed by ΔΗΜΗΤΡΙΟΣ ΔΕΜΟΣ, a national of the Hellenic Republic (the "Applicant"). The application was published for oppositions on March 29, 2022, and received one opposition filed on June 20, 2022 by ITALFARMACO, S.A. on Likelihood of confusion. the opponent was represented by ISERN PATENTES Y MARCAS, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 20, 2022
The application was filed in Greek, and Greek was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003173247 was rejected according to Article 8(1)(b) EUTMR with decision issued on August 17, 2023 by the EUIPO.